Explore the evolution of Clone Trooper armor from Phase I to Phase II, highlighting key design changes and tactical upgrades. This video breaks down the differences in helmet structure, armor ...

Amgen (NASDAQ:AMGN) today announced full results from Part 1 of the Phase 2 study for MariTide (maridebart cafraglutide, formerly AMG 133) in patients living with obesity, with and without Type 2 ...

PHASE 2 is an American graffiti artist known for his pioneering role in the “bubble letter” style of spray painting. Born Michael Lawrence Marrow on August 2, 1955, in Bronx, NY, he began tagging ...

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced ...

The Johannesburg Development Agency (JDA), acting on behalf of the City of Johannesburg’s Transport Department, has begun preparatory work for Phase 2 of the Rosebank Public Transport Facility ...

Clone Troopers wore more than just standard Phase I and Phase II armor some had unique, customized, and highly specialized designs that set them apart. In this video, we explore the most unique ...

Following his loss at The Show of Shows, Cody Rhodes had been absent from WWE programming till the 39th edition of Saturday Night's Main Event. Cena and Rhodes are now set to face each other in ...

The Edge of Fate expansion for Destiny 2 looks like it’s going to reinvent the game from the bottom up, revising, updating, ...

With Phase 2 operational, Metro services will cover 20 km of the total 33.35 km corridor, allowing passengers to travel between Aarey and Worli (Acharya Atre Chowk).

The Edge of Fate promises to overhaul many systems in Destiny 2. One of these systems is how Legendary Armor and Weapons function within the game. The Edge of Fate offers new Gear Tiering, Armor ...

Armed with data from a small phase 1/2 bridging study, MeiraGTx is preparing to take its gene therapy for Parkinson's disease into a pivotal trial. Shares in the Anglo-US biotech rose sharply ...